ROSIELLO, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 291
NA - Nord America 275
AS - Asia 44
SA - Sud America 9
AF - Africa 1
Totale 620
Nazione #
US - Stati Uniti d'America 273
SE - Svezia 218
CN - Cina 26
IT - Italia 25
FI - Finlandia 21
NL - Olanda 11
DE - Germania 10
IN - India 9
PE - Perù 8
HK - Hong Kong 7
IE - Irlanda 3
CA - Canada 2
BG - Bulgaria 1
BR - Brasile 1
EG - Egitto 1
GB - Regno Unito 1
JP - Giappone 1
PL - Polonia 1
VN - Vietnam 1
Totale 620
Città #
Lawrence 50
Princeton 50
New York 38
Ashburn 36
Shanghai 26
Helsinki 21
Lima 8
Milan 8
Dronten 6
Hong Kong 6
Rome 6
Washington 6
Pune 5
Amsterdam 4
Borås 4
Dublin 3
Seattle 3
Cancello e Arnone 2
Hyderabad 2
Al Matariyah 1
Andover 1
Atlanta 1
Crotone 1
Gunzenhausen 1
Ho Chi Minh City 1
Los Angeles 1
Ludhiana 1
Manchester 1
Mountain View 1
Noto 1
Padova 1
Predosa 1
Redwood City 1
Rockville 1
San Antonio 1
São Paulo 1
Temecula 1
Toronto 1
Vaprio d'Adda 1
Varna 1
Winnipeg 1
Yorii 1
Totale 307
Nome #
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 26
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 24
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 24
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 23
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 22
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 22
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 16
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology 16
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 16
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 15
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study 15
Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium 15
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer 13
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 13
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 12
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 12
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 12
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 12
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 12
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 12
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 12
Effect of Age on Cancer-specific Mortality in Patients with Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis across Disease Stages 12
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 11
External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA 11
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract 11
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients 11
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities 11
Bladder cancer incidence rates and trends in young adults aged 20-39 years 11
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis 11
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis 11
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 11
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis 10
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma 10
Salvage pelvic lymph node dissection for lymph node recurrent prostate cancer 10
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 10
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis 9
Contemporary Rates and Predictors of Open Conversion During Minimally Invasive Radical Prostatectomy for Nonmetastatic Prostate Cancer 9
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy 9
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma 9
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study 9
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 8
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities 8
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years 8
Rates of other-cause mortality after radical cystectomy are decreasing over time—A population-based analysis over two decades 8
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study 8
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer 8
Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma 8
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion 8
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients 8
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 7
Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas 7
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy 7
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 7
Small renal masses with tumor size 0 to 2 cm: A SEER-based study and validation of NCCN guidelines 7
Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer 7
The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot-assisted radical prostatectomy: A multi-institutional study 7
The effect of systemic chemotherapy on survival in patients with localized, regional, or metastatic adenocarcinoma of the urinary bladder 6
Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer 6
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study 5
The impact of sex and age on distribution of metastases in patients with renal cell carcinoma 5
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 4
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 2
Totale 689
Categoria #
all - tutte 9.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.911


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 41 0 0 4 0 0 0
2021/202233 0 2 2 13 2 1 0 0 1 0 1 11
2022/2023358 131 84 35 5 6 42 6 29 15 0 1 4
2023/2024253 20 20 29 21 20 52 8 61 7 9 6 0
Totale 689